Akèy › Ateroskleroz › Texas › Houston
Etid klinik pou Ateroskleroz nan Houston, TX
10 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
- Cardiovascular Specialists of Willowbrook, Houston
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Ap rekriteFaz 2
- East Texas Cardiology PA, Houston
- Cardiovascular Specialists of Willowbrook, Houston
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Ap rekriteFaz 3
- Center for Cardiometabolic Disease Prevention/Baylor College of Medicine, Houston
- Orion Medical - Houston, Houston
- Research Physicians Network, LLC, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- ak 2 plis
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
- Clinical Research Strategies, Houston
- DaVita Clinical Research, Houston
- Aqua Research Institute, Houston
- ak 4 plis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Ap rekriteFaz 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- ak 4 plis
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Ap rekriteFaz 3
- Kelsey Seybold Research Foundation, Houston
Pelacarsen Roll-over Extension Program
Ap rekriteFaz 3
- Angiocardiac Care of Texas PA, Houston
- Dallas Heart and Vascular Consultants PA, Houston
- Dallas Heart and Vascular Consultants PA, Houston
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Ap rekriteFaz 4
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Ap rekriteFaz 2
- UT Health Houston, Houston
Etid Ateroskleroz nan lòt vil
- Boston, MA10 etid
- Washington, DC9 etid
- Orlando, FL8 etid
- Arlington, VA8 etid
- Hialeah, FL8 etid
- Durham, NC7 etid
- Dallas, TX7 etid
- Memphis, TN7 etid
- Miami, FL7 etid
- Las Vegas, NV7 etid
- San Diego, CA6 etid
- Santa Monica, CA6 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.